When a calculation result is off by one yen, simply adding round at the end does not always solve the problem. The result ...
Capping off an extraordinary year that finished with a Super Stock-class offshore racing world championship followed by a fourth F1H2O tunnel-boat world title, Shaun Torrente is making a big move into ...
Tokens Are New AI Currency. Here's Everything You Need to Understand Before You Spend Another Dollar
Every AI model runs on tokens. Every API bill is a token bill. Every context window limit is a token limit. Every speed difference between models comes down to how many tokens they process per second.
The shift from analogue film to digital video happened quickly. Before you knew it, tape-based video recorders had been replaced with digital video cameras and, later still, smartphones. 4K is now the ...
WASHINGTON — The U.S. Space Force awarded contracts totaling $615 million to Rocket Lab, Systems & Technology Research and a third unidentified company to develop technologies for a satellite network ...
Upon completion of the acquisition, KKR said it intends to establish a “broad-based employee ownership and engagement program” consistent with the investment firm’s strategy of cultivating an ...
Investment firm KKR KKR-0.12%decrease; down pointing triangle has struck a deal to acquire medical-device outsourcing company Integer Holdings ITGR 0.05%increase; up pointing triangle for about $4.3 ...
Integer Holdings has entered into a definitive agreement to be acquired by KKR in an all-cash transaction valued at approximately $5.7 billion. Under the agreement, Integer shareholders will receive ...
KKR will pay $127 per share in cash; deal includes assumption of Integer's debt Acquisition will deepen KKR's healthcare exposure Integer supplies cardiac, pain-management components to major ...
July 31 (Reuters) - Private equity firm KKR (KKR.N), opens new tab is nearing a takeover of medical device outsourcing company Integer Holdings (ITGR.N), opens new tab, the Wall Street Journal ...
Allogeneic CD19-targeted CAR-T therapy (BRL-301) for relapsed or refractory B-cell acute lymphoblastic leukemia (r/r B-ALL). This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results